Literature DB >> 17506097

Detection of a de novo interstitial 2q microdeletion by CGH microarray analysis in a patient with limb malformations, microcephaly and mental retardation.

Annika M Svensson1, Cynthia J Curry, Sarah T South, Heidi Whitby, Teresa M Maxwell, Emily Aston, Jamie Fisher, C E Carmack, Alicia Scheffer, Aimee Abu-Shamsieh, Arthur R Brothman.   

Abstract

We describe the cytogenetic diagnosis using BAC- and oligonucleotide microarrays of a 16-year-old Laotian-American female, who first presented at 2 1/2 years of age with microcephaly, developmental retardation, and skeletal abnormalities of the upper limb including mild syndactyly of the second and third and the third and fourth fingers, short middle phalanges and clinodactyly of the fifth digit at the distal interphalangel joint on both hands, and symphalangism of the metacarpal-phalangeal joints of the second and fifth digits bilaterally. Her lower limbs displayed symphalangism of the metatarsal-phalangeal joint of the second, third, and fourth digits on both feet, with fusion of the middle and distal phalanges of the second and fifth digits and hallux valgus bilaterally. G-banded chromosomal study at age 4 was normal. However, comparative genomic hybridization at age 15 with the Spectral Genomics 1 Mb Hu BAC array platform indicated a microdeletion involving two BAC clones, RP11-451F14 --> RP11-12N7 at 2q31.1. The maximal deletion on initial analysis comprised the HOXD cluster, which is implicated in limb development. Fluorescence in situ hybridization (FISH) using the RP11-451F14 probe confirmed the deletion. Both parents were negative for the deletion. Additional FISH using BAC RP11-387A1, covering the HOXD cluster, limited the maximal deletion to approximately 2.518 Mb, and excluded involvement of the HOXD cluster. The Agilent 44K and 244K platforms demonstrated a deletion of approximately 2,011,000 bp, which did not include the HOXD cluster. The malformations in our patient may be caused by deletion of a regulatory element far upstream of the HOXD cluster.

Entities:  

Mesh:

Year:  2007        PMID: 17506097     DOI: 10.1002/ajmg.a.31775

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  8 in total

1.  Refinement of the Region for Split Hand/Foot Malformation 5 on 2q31.1.

Authors:  A Theisen; J A Rosenfeld; K Shane; K L McBride; J F Atkin; C Gaba; J Hoo; T W Kurczynski; R E Schnur; L B Coffey; E H Zackai; L Schimmenti; N Friedman; M Zabukovec; S Ball; R Pagon; A Lucas; C K Brasington; J E Spence; S Sparks; V Banks; W Smith; T Friedberg; P R Wyatt; M Aust; R Tervo; A Crowley; D Skidmore; A N Lamb; B Ravnan; T Sahoo; R Schultz; B S Torchia; M Sgro; D Chitayat; L G Shaffer
Journal:  Mol Syndromol       Date:  2011-05-18

2.  Severe Progressive Autism Associated with Two de novo Changes: A 2.6-Mb 2q31.1 Deletion and a Balanced t(14;21)(q21.1;p11.2) Translocation with Long-Range Epigenetic Silencing of LRFN5 Expression.

Authors:  D R H de Bruijn; A H A van Dijk; R Pfundt; A Hoischen; G F M Merkx; G A Gradek; H Lybæk; A Stray-Pedersen; H G Brunner; G Houge
Journal:  Mol Syndromol       Date:  2010-02-12

3.  High frequency of copy number imbalances in Rubinstein-Taybi patients negative to CREBBP mutational analysis.

Authors:  Cristina Gervasini; Federica Mottadelli; Roberto Ciccone; Paola Castronovo; Donatella Milani; Gioacchino Scarano; Maria Francesca Bedeschi; Serena Belli; Alba Pilotta; Angelo Selicorni; Orsetta Zuffardi; Lidia Larizza
Journal:  Eur J Hum Genet       Date:  2010-02-03       Impact factor: 4.246

4.  Duplication at chromosome 2q31.1-q31.2 in a family presenting syndactyly and nystagmus.

Authors:  Jamal Ghoumid; Joris Andrieux; Bernard Sablonnière; Sylvie Odent; Nathalie Philippe; Xavier Zanlonghi; Pascale Saugier-Veber; Thomas Bardyn; Sylvie Manouvrier-Hanu; Muriel Holder-Espinasse
Journal:  Eur J Hum Genet       Date:  2011-06-08       Impact factor: 4.246

5.  Developmental genomics of limb malformations: Allelic series in association with gene dosage effects contribute to the clinical variability.

Authors:  Ruizhi Duan; Hadia Hijazi; Elif Yilmaz Gulec; Hatice Koçak Eker; Silvia R Costa; Yavuz Sahin; Zeynep Ocak; Sedat Isikay; Ozge Ozalp; Sevcan Bozdogan; Huseyin Aslan; Nursel Elcioglu; Débora R Bertola; Alper Gezdirici; Haowei Du; Jawid M Fatih; Christopher M Grochowski; Gulsen Akay; Shalini N Jhangiani; Ender Karaca; Shen Gu; Zeynep Coban-Akdemir; Jennifer E Posey; Yavuz Bayram; V Reid Sutton; Claudia M B Carvalho; Davut Pehlivan; Richard A Gibbs; James R Lupski
Journal:  HGG Adv       Date:  2022-08-04

6.  2q31.1 microdeletion syndrome: case report and literature review.

Authors:  Surasak Puvabanditsin; Melissa February; Tazeem Shaik; Arun Kashyap; Chantal Bruno; Rajeev Mehta
Journal:  Clin Case Rep       Date:  2015-03-29

7.  Prioritization of genes driving congenital phenotypes of patients with de novo genomic structural variants.

Authors:  Sjors Middelkamp; Judith M Vlaar; Jacques Giltay; Jerome Korzelius; Nicolle Besselink; Sander Boymans; Roel Janssen; Lisanne de la Fonteijne; Ellen van Binsbergen; Markus J van Roosmalen; Ron Hochstenbach; Daniela Giachino; Michael E Talkowski; Wigard P Kloosterman; Edwin Cuppen
Journal:  Genome Med       Date:  2019-12-04       Impact factor: 11.117

8.  A novel chromosome 2q24.3-q32.1 microdeletion in a fetus with multiple malformations.

Authors:  Mianmian Zhu; Yihong Wang; Lijie Guan; Chaosheng Lu; Rongyue Sun; Yuan Chen; Jiamin Shi; Yanying Zhu; Dan Wang
Journal:  J Clin Lab Anal       Date:  2022-07-12       Impact factor: 3.124

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.